Abstract Details
|
Danielle Wilhour, MD
(University of Colorado)
PRESENTER |
Dr. Wilhour has nothing to disclose. |
| Samantha K. Holden, MD, MS, FAAN (University of Colorado School of Medicine) | The institution of Dr. Holden has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics. |
| Katy Alpogianis | No disclosure on file |
| Douglas Ney, MD, FAAN | The institution of Dr. Ney has received research support from Orbus Therapeutics. The institution of Dr. Ney has received research support from Denovo Biopharma. |